Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

06. November 2025 08:02 ET | Quelle: Cytrellis Biosystems

Cytrellis Secures FDA Clearance for Full Body Resurfacing Using Ellacor® Micro-Coring® Technology

FDA Clears Cytrellis' ellacor® Micro-Coring® Technology for Full-Body Resurfacing, expanding applications to treat sagging skin beyond the face.
02. Juni 2025 09:02 ET | Quelle: Cytrellis Biosystems

Cytrellis Strengthens Leadership Team in Support of Accelerated Commercial Growth of ellacor® Platform

Cytrellis Biosystems' leadership team will support the accelerated commercialization of ellacor platform and expand Cytrellis' market presence.
18. März 2025 08:05 ET | Quelle: Cytrellis Biosystems

Cytrellis Secures Health Canada and Saudi Food and Drug Authority Approval for ellacor® with Micro-Coring® Technology

Cytrellis Biosystems has received approval to commercialize its groundbreaking ellacor® with Micro-Coring® technology in Canada and Saudi Arabia.
06. März 2025 08:00 ET | Quelle: Cytrellis Biosystems

Cytrellis’ Next-Generation ellacor® Optimizes Micro-Coring for Enhanced Patient and Provider Experience

Cytrellis' next-generation ellacor® system with Micro-Coring® enhances patient and provider experience. It will be showcased at industry conferences.
07. Januar 2025 08:15 ET | Quelle: Cytrellis Bioscience

Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financing

Cytrellis marks new era of growth with the launch of ellacor 2.0, fueled by the completion of new financing and theappointment of Dr. Denise Dajles as CEO.